Home/Pipeline/Hyaluronic Acid-based Therapies

Hyaluronic Acid-based Therapies

Tendinopathy, Osteoarthritis, Dry Eye Disease

Commercial / Lifecycle ManagementActive

Key Facts

Indication
Tendinopathy, Osteoarthritis, Dry Eye Disease
Phase
Commercial / Lifecycle Management
Status
Active
Company

About TRB Chemedica International

TRB Chemedica International is a well-established, privately-held Swiss pharma and biotech company with over 40 years of history. It has a global commercial footprint, supported by over 900 employees, 20+ international subsidiaries, and manufacturing sites in Switzerland, Argentina, and Brazil. The company's strategy centers on developing and marketing specialized products in ophthalmology, rheumatology, and neurology, built on deep expertise in key therapeutic compounds and a partnership-driven business model that includes in-licensing and out-licensing.

View full company profile